{
    "clinical_study": {
        "@rank": "116087", 
        "arm_group": {
            "arm_group_label": "CPA treatment", 
            "description": "CPA treatment group receives 20 hours of patient centered manual physical therapy"
        }, 
        "brief_summary": {
            "textblock": "This study will examine the impact of manual physical therapy on endocrine function in women\n      diagnosed as being infertile due to elevated follicle stimulating hormone (FSH) levels (10\n      mIU/mL or higher) on days 2-5 of their menstrual cycle.  It is hypothesized that the manual\n      physical therapy will decrease FSH levels."
        }, 
        "brief_title": "Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "FSH Hypersecretion", 
            "Endocrine System Diseases", 
            "Infertility"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Endocrine System Diseases", 
                "Infertility"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study will investigate the effect of manual physical therapy on the endocrine levels of\n      women by comparison of pre- and post- treatment hormone levels (FSH, LH and Estradiol).\n      Secondary measures include assessment of pain and sexual function  via questionnaires.\n\n      Hormones will be measured at prescribed time points:\n\n        -  baseline: 30-60 days before treatment\n\n        -  pre-treatment: 7-30 days before treatment\n\n        -  post treatment 1: 10-30 days post treatment\n\n        -  post treatment 2: 30-60 days post treatment\n\n      Pain and sexual function questionnaires will be completed:\n\n        -  baseline: 30-60 days before treatment\n\n        -  pre-treatment: 7-30 days before treatment\n\n        -  post treatment 1: 30 days post treatment\n\n        -  post treatment 2: 60 days post treatment"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosed as infertile\n\n          -  FSH greater than 10mIU/mL on days 2-5 of menstrual cycle\n\n          -  Regular menstrual cycle\n\n          -  Residing in the US, accessible to a LabCorp testing facility\n\n        Exclusion Criteria:\n\n          -  Active infection including HIV or inflammation\n\n          -  Cancer within the past 5 years\n\n          -  Currently pregnant\n\n          -  Hemophilia, abnormal bleeding or clotting disorder\n\n          -  Immune system disorder\n\n          -  Abnormal ovarian cyst or endometrioma\n\n          -  BMI of 35 or greater\n\n          -  Any other condition in which deep manual physical therapy is contraindicated\n\n          -  Currently taking any fertility medications or planning to take any fertility related\n             medications during the course of the study. This includes all ovarian stimulating\n             medications, artificial hormones and birth control medications.\n\n          -  Participation in any assisted reproductive technique (such as IVF) other than\n             intra-uterine insemination during the course of the study."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Women with elevated FSH levels that undergo the CPA treatment"
            }
        }, 
        "enrollment": {
            "#text": "67", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 2, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02027168", 
            "org_study_id": "FSH-2012-001"
        }, 
        "intervention": {
            "arm_group_label": "CPA treatment", 
            "description": "Site specific, patient centered manual physical therapy regimen focused on restoring function to the entire body", 
            "intervention_name": "CPA", 
            "intervention_type": "Other", 
            "other_name": [
                "Clear Passage Approach", 
                "Wurn Technique"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "infertility", 
            "elevated FSH", 
            "alternative treatment", 
            "Clear Passage Approach", 
            "Clear Passage Physical Therapy"
        ], 
        "lastchanged_date": "January 2, 2014", 
        "link": [
            {
                "description": "Related Info", 
                "url": "http://www.clearpassage.com/what-we-treat/infertility/fsh-hormonal-problems/"
            }, 
            {
                "description": "Study Website", 
                "url": "http://www.clearpassage.com/fsh-study/"
            }
        ], 
        "location": {
            "contact": {
                "email": "research@clearpassage.com", 
                "last_name": "Amanda Rice, Ph.D.", 
                "phone": "352-336-1433"
            }, 
            "facility": {
                "address": {
                    "city": "Gainesville", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32606"
                }, 
                "name": "Clear Passage Physical Therapy"
            }, 
            "investigator": {
                "last_name": "Lawrence J Wurn, LMT", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women", 
        "overall_official": {
            "affiliation": "Clear Passage Physical Therapy", 
            "last_name": "Lawrence J Wurn, LMT", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change in FSH, LH and estradiol levels from baseline and pre-treatment, baseline and 30 and 60 day post treatment.", 
            "measure": "Change in endocrine levels post treatment", 
            "safety_issue": "No", 
            "time_frame": "baseline, pre-treatment and 30 and 60 days post treatment"
        }, 
        "reference": [
            {
                "PMID": "18251317", 
                "citation": "Wurn BF, Wurn LJ, King CR, Heuer MA, Roscow AS, Hornberger K, Scharf ES. Treating fallopian tube occlusion with a manual pelvic physical therapy. Altern Ther Health Med. 2008 Jan-Feb;14(1):18-23."
            }, 
            {
                "PMID": "15775874", 
                "citation": "Wurn LJ, Wurn BF, King CR, Roscow AS, Scharf ES, Shuster JJ. Increasing orgasm and decreasing dyspareunia by a manual physical therapy technique. MedGenMed. 2004 Dec 14;6(4):47."
            }, 
            {
                "PMID": "15266276", 
                "citation": "Wurn BF, Wurn LJ, King CR, Heuer MA, Roscow AS, Scharf ES, Shuster JJ. Treating female infertility and improving IVF pregnancy rates with a manual physical therapy technique. MedGenMed. 2004 Jun 18;6(2):51. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02027168"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Pain levels and sexual function before treatment as compared to baseline.", 
                "measure": "Pain levels and sexual function before treatment", 
                "safety_issue": "No", 
                "time_frame": "30 days before treatment"
            }, 
            {
                "description": "Pain levels and sexual function as measured by survey 30 days post treatment compared to baseline.", 
                "measure": "Pain levels and sexual function post treatment", 
                "safety_issue": "No", 
                "time_frame": "30 days post treatment"
            }, 
            {
                "description": "Pain levels and sexual function as measured by survey 60 days post treatment compared to baseline.", 
                "measure": "Pain levels and sexual function post treatment", 
                "safety_issue": "No", 
                "time_frame": "60 days post treatment"
            }, 
            {
                "description": "Subjects will be monitored for natural intrauterine pregnancy for the duration of the study.", 
                "measure": "Pregnancy", 
                "safety_issue": "No", 
                "time_frame": "study duration; 60 days post treatment"
            }
        ], 
        "source": "Clear Passage Therapies, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Clear Passage Therapies, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}